NCT06943768Not yet recruiting
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes for the Early Diagnosis and Screening of Gastric Cancer
Source: ClinicalTrials.gov · Last updated 24 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a multicenter, cross-sectional study. It is based on fecal methylation site detection, H. pylori susceptibility testing of fecal samples, and a combination of the two, compared with the "gold standard" imaging tests, CT, gastroscopy and/or pathology, for gastric cancer, benign diseases such as gastritis, and health check-ups.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 9654 (estimated)
- First submitted
- 20 Mar 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- Fudan University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06943768
What you commit to
- Study type: Observational
- Planned participants: 9654
- From 1 Dec 2025 to the primary completion date, 30 Apr 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders.
- A previous history of malignant tumors of the upper gastrointestinal tract.
Other
- Women during pregnancy.
- Those with undefined pathology.
- Those with unsatisfactory sample retention (e.g., too small a sample size)
Who the study is looking for
- Age ≥ 18 years old, male or female not limited.
- Within 90 days, the gastroscopy and/or pathological results confirm the absence of gastric cancer.
- Patients must be able to fully understand the informed consent form and be able to personally sign it.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.